Cover Image

Analysis of haematinic preparations available in Indian pharmaceutical market



OBJECTIVE To analyze the haematinic preparations available in Indian pharmaceutical market according to their dosage forms, iron salts used, rationality, additional     nutrients, frequency of administration and cost of treatment per day. MATERIALS AND METHODS Haematinic preparations listed in Indian Drug Review (2012) were analyzed for their types of dosage form, iron salts used, rationality, content of elemental iron, frequency of administration, additional    nutrients, and cost. Preparations containing iron with or without folic acid or vitamin C were considered as rational formulations. Since the recommended therapeutic dose of iron is 100 to 200 mg elemental iron daily in three divided doses, cost comparison was done by calculating the cost of 100 mg of elemental iron available from each formulation. If information about the type of iron salt, or quantity, or cost were not  available, such formulations were not included for the cost    analysis. Prices of rational iron preparations were compared with that of irrational formulations. RESULTS Out of 511              formulations,287 were oral solid formulations,202 were oral liquids formulations, and 22 were for parenteral                            administration.57 of the solid oral formulations and 60 of the liquid oral formulations were classified under iron, folic acid and others sub group.As many as 71 of the solid oral                        preparations,65 of the liquid oral iron preparations and 9 of       parenteral iron formulations were found to be irrational. Among the 287 oral (solid) iron formulations, we found that 53 would require administration more than three times a day to provide a therapeutic dosage of elemental iron. As compared to the costs of irrational solid formulations(range Rs.1.2 to Rs.92.5),the costs of rational solid formulations(range Rs.6 to Rs.70) was in a  significantly narrow range. However, the average cost of rational products was significantly higher than that of the irrational ones. Formulations containing iron salts like ferrous sulphate, carbonyl iron, and ferrous fumarate are cheaper than formulations   containing other newer iron salts. CONCLUSION The drug  regulation authorities should have a check over the irrational formulations and tune the drug price in such a way that rational formulations cost less than the irrational ones.


Full Text:



India’s undernourished children: A call for reform and action, World bank report:


Sunita S. Patil, Chitra C. Khanwelkar, Sunil. K. Patil. Conventional and newer oral iron preparations. International Journal of Medical and Pharmaceutical Sciences. 2012;2(3): 16-22

Bafna Pharma to focus on haematinic drug mkt. [Last accessed on 2011 June 23]. Available from: h t t p : / / s m a r t i n v e s t o r . i n / c o m p a n y / c N e w s - c n e w s d e t - 6 9 3 3 5 - 2 8 6 1 1—Bafna_Pharma_to_focus_on_haematinic_drug_mkt -Bafna_Pharmaceuticals_Ltd.htm .

Kaushansky K, Kipps TJ. Hematopoietic agents. In: Brunton L, Chabner B, Knollman B. (eds.) Goodman and Gilman's The pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2006: 1067–1085.

Shah A. Iron deficiency anemia - Part III. Indian J Med Sci. 2004;58:214 -216. [PubMed]

Tripathi KD. Haematinics and Erythropoietin. Essentials of medical pharmacology. 6th ed. New Delhi: Jaypee Brothers Medical Publishers; 2008: 581–592.

Ingle PV, Gandhi AG, Patil PH, Surana SJ. Iron Deficiency Anemia: Perspectives in Indian Pregnant Women. Research

Journal of Pharmaceutical, Biological and Chemical Sciences. 2011; 2(3): 1036-1047

Rasner F. Shotgun haematinic therapy. Arch Intern Med. 1978;138:1129. [PubMed]

Page C, Curtis M, Walker M, Hoffman B. Drugs and the blood. Integrated Pharmacology. 3rd ed. India:Elsevier publishers. 2009:277-281

Udayakumar P. Haematopoietic system. Medical Pharmacology. 3rd ed. India:CBS publishers and distributers pvt lmt. 2011:327-329

Christian P, Shrestha J, LeClerq SC, Khatry SK, Jiang T, Wagner T, Katz J & West KP. Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal. The Journal of Nutrition. 2003;133: 3492–3498.

Srivastava SK. Haematinics. A complete textbook of medical pharmacology. India:Avichal publishing company. 2012;1:343-350

E M De Maeyer Former medical officer. Nutrition, World Health Organization, Geneva Switzerland. Preventing controlling iron deficiency anaemia through primary health care. A guide for health administrators and programme managers.

Siddharth Z, Shah N, Paul Anand M. API text book of medicine 7th Ed. pg 931.

Sweetman SC. Martindale the complete drug reference. 35th ed. London: RPS publishing; 2007;1:1762–836.

Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Washington, DC: National Academy Press, 2001.

Rossander-Hulten L, Brune M, Sandstrom B, Lonnerdal B, Hallberg L. Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr. 1991;54:152– 156.

Crofton RW, Gvozdanovic D, Gvozdanovic S, et al. Inorganic zinc and the intestinal absorption of ferrous iron. AmJ Clin Nutr. 1989;50:141– 144.

Dawson EB, McGanity WJ. Bioavailability of iron in prenatal multivitamin/multimineral supplements administered to pregnant teenagers. Clin Ther. 1988;10:429 –35.

Lind T, Lonnerdal B, Stenlund H, et al. Acommunity-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: interactions between iron and zinc. Am J Clin Nutr. 2003;77:883–90.

Fawzie WW, Msamanga GI, Spiegelman D, Urassa EJN, McGrath N, Mwakagile D, Antelman G, Mbise R, Herrera G, Kapiga S, Willett W, Hunter DJ & the Tanzania Vitamin & HIV Infection Trial Team. Randomized trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet. 1998;351: 1477–1482.

Ramakrishnan U, Neufeld LM, Gonza´lez-Cossío T, et al. Multiple micronutrient supplements during pregnancy do not reduce anemia or improve iron status compared to iron-only supplements in semi-rural Mexico. The Journal of Nutrition. 2004;134:898 –904.

Christian P, Khatry SK, Katz J, Pradhan EK, LeClerq SC, Shrestha SR, Adhikari RK, Sommer A & West KP Jr. Effects of alternative maternal micronutrient supplements on low birth weight in rural Nepal: double blind randomised community trial. Br. Med. J. 2003;326: 571–579.

Devasthali SD, Gordeuk VR, Brittenham GM, Hughes MA, Bravo JR, Hughes MA, Keating LJ. Bioavailability of carbonyl iron a randomized, double blind study. Eur J Haematol.1991;46(5):272-278.

Adsul BB, Desai A, Gawde A, Baliga V. Comparative assessment of the bioavailability, efficacy and safety of carbonyl iron and oral conventional iron preparation. J Indian Med Assoc. 2005;103(6):338-342.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University